These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 2957045

  • 1. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
    Ruzicka FJ, Schmid SM, Groveman DS, Cummings KB, Borden EC.
    Cancer Res; 1987 Sep 01; 47(17):4582-9. PubMed ID: 2957045
    [Abstract] [Full Text] [Related]

  • 2. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
    Rosenblum MG, Yung WK, Kelleher PJ, Ruzicka F, Steck PA, Borden EC.
    J Interferon Res; 1990 Apr 01; 10(2):141-51. PubMed ID: 2140395
    [Abstract] [Full Text] [Related]

  • 3. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
    Schiller JH, Horisberger MA, Bittner G, Carlin JM, Storer B, Byrne GI, Willson JK, Borden EC.
    J Biol Response Mod; 1990 Aug 01; 9(4):368-77. PubMed ID: 2395002
    [Abstract] [Full Text] [Related]

  • 4. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
    Schiller JH, Bushmeyer SM, Ruzicka FJ, Princler GL, Faltynek CR, Borden EC.
    Cancer Res; 1990 Jan 01; 50(1):26-31. PubMed ID: 2136700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.
    Goldstein D, Bushmeyer SM, Witt PL, Jordan VC, Borden EC.
    Cancer Res; 1989 May 15; 49(10):2698-702. PubMed ID: 2469536
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biological activities and receptor binding of two human recombinant interferons and their hybrids.
    Meister A, Uzé G, Mogensen KE, Gresser I, Tovey MG, Grütter M, Meyer F.
    J Gen Virol; 1986 Aug 15; 67 ( Pt 8)():1633-43. PubMed ID: 3016158
    [Abstract] [Full Text] [Related]

  • 11. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J, Gaudelet C, Aguet M, Falcoff E.
    J Immunol; 1986 Apr 01; 136(7):2451-5. PubMed ID: 2936825
    [Abstract] [Full Text] [Related]

  • 12. Biological and clinical effects of interferon-beta ser at two doses.
    Borden EC, Rinehart JJ, Storer BE, Trump DL, Paulnock DM, Teitelbaum AP.
    J Interferon Res; 1990 Dec 01; 10(6):559-70. PubMed ID: 2086672
    [Abstract] [Full Text] [Related]

  • 13. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH, Storer B, Paulnock DM, Brown RR, Datta SP, Witt PL, Borden EC.
    J Clin Invest; 1990 Oct 01; 86(4):1211-21. PubMed ID: 2120284
    [Abstract] [Full Text] [Related]

  • 14. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL, Spear GT, Helgeson DO, Lindstrom MJ, Smalley RV, Borden EC.
    J Interferon Res; 1990 Aug 01; 10(4):393-402. PubMed ID: 2121851
    [Abstract] [Full Text] [Related]

  • 15. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells.
    Yamaoka T, Kojima S, Ichi S, Kashiwazaki Y, Koide T, Sokawa Y.
    J Interferon Cytokine Res; 1999 Dec 01; 19(12):1343-9. PubMed ID: 10638703
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
    Kinney P, Triozzi P, Young D, Drago J, Behrens B, Wise H, Rinehart JJ.
    J Clin Oncol; 1990 May 01; 8(5):881-5. PubMed ID: 2332772
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to chromosome 21 coded cell surface components block binding of human alpha interferon but not gamma interferon to human cells.
    Shulman LM, Kamarck ME, Slate DL, Ruddle FH, Branca AW, Baglioni C, Maxwell BL, Gutterman J, Anderson P, Nagler C, Vilcek J.
    Virology; 1984 Sep 01; 137(2):422-7. PubMed ID: 6237488
    [Abstract] [Full Text] [Related]

  • 18. Structure/function studies on recombinant human gamma interferon.
    Fish EN, Banerjee K, Arakawa T, Stebbing N.
    Drug Des Deliv; 1988 Feb 01; 2(3):191-206. PubMed ID: 2855574
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.